Specialty pharma co Rubicon acquires Cipla unit Meditab's manufacturing facility in Satara

Rubicon Research Pvt Ltd, a specialty pharmaceutical company backed by General Electric, has acquired Cipla Ltd's wholly-owned subsidiary Meditab Specialities Ltd's oral liquid dosage and nasal product manufacturing facility in Satara, Maharashtra. The facility is cGMP compliant and MHRA (UK) inspected the production site that enables a diverse pipeline of oral liquids for Rubicon Research. The company will seek additional regulatory approvals at the Satara site, including from the US FDA.